By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Yissum Ltd. 

Research Development Company
of The Hebrew University of Jerusalem Ltd.

High-Tech Park, Edmond J. Safra Campus
Givat Ram, P.O. Box 39135

Jerusalem    91390  Israel
Phone: 972-2-658-6693 Fax: 972-2-658-6689



Company News
Therapix Signs Exclusive License Agreement With Yissum Ltd. For Nasal Drug Delivery Technology 4/5/2017 8:06:09 AM
Phytecs, Leading U.S. Biotech Focused On The Endocannabinoid System, Partners With Yissum Ltd. To Discover New ECS-Targeting Compounds, Test Potential Of Fluorinated CBD 2/22/2017 7:27:13 AM
Kamada Ltd. (KMDA) Announces Collaboration Agreement With Yissum Ltd. For Development Of A Recombinant Human Alpha 1 Antitrypsin 11/15/2016 9:23:48 AM
Agrinnovation, Yissum Ltd.'s Agritech Investment Fund, Invests In Medical Cannabis Startup, Cannabi-Tech 9/22/2016 11:04:43 AM
Therapix Signed A Binding MOU With Yissum Ltd., The Technology Transfer Company Of The Hebrew University Of Jerusalem, To Receive A License To Use A Formulation For Nasal Administration Of Cannabinoid Substances 7/5/2016 6:33:54 AM
Yissum Ltd. To Receive $1.2 Million Of Funding From Aurum Ventures For Development Of Novel Diagnostic Platform 5/23/2016 9:14:37 AM
Yissum Ltd. And BioTheryX Sign Licensing Agreement For The Development Of Next-Generation Protein Degradation And Immunomodulatory Treatment For Hematological Cancers 5/4/2016 6:32:21 AM
Yissum Ltd. Forms Neteera Technologies Ltd. For Remote Sensing Of Biological Indicators 3/15/2016 8:32:58 AM
Yissum Ltd. Announces Formation Of Agritech Investment Fund 10/26/2015 10:52:05 AM
Yissum Ltd. Introduces A Novel Technology For Drug Screening And Testing Of Orphan Diseases Without Utilizing Animal Models 7/27/2015 10:30:01 AM